Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
CVS has reportedly put in an offer to buy Aetna. Photo: AP file
CVS on Sunday night said that it will acquire health insurer Aetna for around $69 billion in cash and stock. Four big questions that remain unanswered by this evening's press release:
1. What will be the relationship between CVS and those covered by Aetna insurance? For example, will an Aetna customer be required to purchase medications within the CVS network, or use urgent care facilities for services that can be handled by CVS MinuteClinic? If not, will there be surcharges for going to a rival pharmacy?
2. CVS and Aetna discussed data synergies, but how far will those extend? For example, will your health insurer learn about your junk food habit?
3. How will this affect negotiations between non-Aetna insurers and CVS? Will Aetna rivals play hardball with CVS and/or softball with other pharmacies?
4. Will other pharmacy chains feel pressure to do a similar acquisition? Big CVS rivals like Walmart, Kroger and Walgreens could soon take a hard look at insurers like Anthem, Cigna, Humana and United Health. And how does Amazon — which is rumored to be looking at both pharmacy and pharma — react?
- Go deeper: Bob Herman on central questions behind this deal, from when it was first rumored in October.